A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment

Peer Review reports

Original Submission
12 Mar 2010	Submitted	Original manuscript
15 Aug 2010	Reviewed	Reviewer Report - Markus Buchler
31 Aug 2010	Author responded	Author comments - Nikol Snoeren
Resubmission - Version 2
31 Aug 2010	Submitted	Manuscript version 2
Publishing
11 Oct 2010	Editorially accepted
11 Oct 2010	Article published	10.1186/1471-2407-10-545

Back to article page